Blog
RSS FeedPosted by Michael Wonder on 11 Apr 2024
NICE issues final draft guidance for use of remdesivir and also for tixagevimab-cilgavimab (Evusheld) for treatment of COVID-19
9 April 2024 - Final draft guidance for remdesivir and for tixagevimab with cilgavimab has been published by NICE. ...
Posted by Michael Wonder on 22 Jan 2024
NICE issues draft guidance for use of remdesivir and also for tixagevimab-cilgavimab for treatment of COVID-19
18 January 2024 - Draft guidance for public consultation has been published by NICE. ...
Posted by Michael Wonder on 28 Nov 2022
Joint statement: NICE and SMC/HIS collaboration
25 November 2022 - NICE and SMC/HIS collaboration on the health technology appraisal of tixagevimab–cilgavimab (Evusheld) for preventing COVID-19. ...
Posted by Michael Wonder on 23 Sep 2020
SMC plays key role in helping to secure access to COVID-19 treatments
15 September 2020 - The Scottish Medicines Consortium is part of a UK-wide multi-agency initiative to secure access to potential ...
Posted by Michael Wonder on 25 May 2020
SMC response to COVID-19
22 May 2020 - To prioritise and support the capacity of health and social care services, Healthcare Improvement Scotland and the ...